CMTTdb

An integrated database for cancer molecular targeted thearpies

View Agent


Agent Info
Agent:AMG102
Synonyms:rilotumumab
Drug Status For Certain Diseases:Discontinued inphase 2(Grade IV malignant glioma;Glioblastoma multiforme)
Classification:a fully human monoclonal antibody against hepatocyte growth factor/scatter factor (HGF/SF)
Target:hepatocyte growth factor/scatter factor (HGF/SF)
KEGG Pathway:Renal cell carcinoma
Pathways in cancer
Malaria
Focal adhesion
Cytokine-cytokine receptor interaction
Melanoma
Proteoglycans in cancer
Rap1 signaling pathway
PI3K-Akt signaling pathway
Ras signaling pathway
Wiki Pathway:Prostate Cancer
Interleukin-7 signaling
NRF2 pathway
Nuclear Receptors Meta-Pathway
Differentiation Pathway
Focal Adhesion
Extracellular vesicle-mediated signaling in recipient cells
Signaling of Hepatocyte Growth Factor Receptor